NasoNeb Delivery of an Intranasal Steroid

Exclusion Criteria

• •1. Physical signs or symptoms suggestive of renal, hepatic or cardiovascular disease.
• •2. Pregnant or lactating women.
• •3. Subjects treated with systemic steroids during the previous 30 days.
• •4. Subjects treated with topical (inhaled, intranasal or intraocular) steroids, Nasalcrom or Opticrom during the previous 30 days.
• •5. Subjects treated with oral antihistamine/decongestants during the previous seven days.
• •6. Subjects treated with topical (intranasal or intraocular) antihistamine/decongestants during the previous 3 days.
• •7. Subjects treated with immunotherapy and are escalating their dose.
• •8. Subjects on chronic anti-asthma medications.
• •9. Subjects with polyps in the nose or a significantly displaced septum.
• •10. Upper respiratory infection within 14 days prior to study start.